Kutatási jelek – Signal Engine

• AbbVie Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Diffuse large B-cell lymphoma
• Study Reveals How Leukemia Cells Enter and Damage Lungs — Leukemia
• Overcoming PD‑1 Resistance in Relapsed/Refractory Hodgkin Lymphoma — Hodgkin lymphoma
• Cutaneous eruptions associated with Lifileucel response in metastatic melanoma — Melanoma
• The role of TP53 mutations in oral cancer: molecular mechanisms and prognostic implications — Gastrointestinal stromal tumor
• Improving Access to High-Quality Sarcoma Care: Practical Delivery Models to Reduce Delays, Disparities, and Financial Toxicity — Ewing sarcoma
• SystImmune Announces First Approval of Iza-bren for the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma in China — Nasopharyngeal carcinoma
• How Are Key Lymphoma Data From ASCO and EHA 2026 Shaping Treatment? — Lymphoma
• Understanding LFS Biology and Core Cancers — Breast cancer
• Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial — Gastrointestinal stromal tumor
• Colorectal cancer research reveals new mechanism in targeted therapy against metastasis — Colorectal cancer
• World's largest genetic study of 'moliness' helps unravel mysteries of melanoma — Melanoma
• Why glioblastoma keeps beating treatment: Hidden signaling axis could open new drug path — Glioblastoma
• Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial) — Gastrointestinal stromal tumor
• Lurbinectedin Misses Survival Endpoint in Relapsed SCLC Trial — SCLC
• Chronic Myeloid Leukemia (CML) Treatment & Management: Approach Considerations, Imatinib, Newer Tyrosine Kinase Inhibitors — Acute lymphoblastic leukemia
• Chronic Myeloid Leukemia (CML): Background, Pathophysiology, Epidemiology — Leukemia
• The dual axis of tumorigenesis: MAPK and PI3K/AKT pathways in papillary thyroid carcinoma — Thyroid cancer
• SEVABERTINIB – Application in Therapy and Current Clinical Research — NSCLC
• Breast cancer: further evidence supporting the clinical use of circulating biomarkers — Breast cancer